GC-MS: fundamental tool for the analysis of drugs of illicit use

Stashenko, Elena E.; Martínez, Jairo R.

Palavras-chave: Gas chromatography, gas chromatography-mass spectrometry, controlled substances, drugs.

ResumoThe chromatographic determination of illicit drugs poses important challenges at various stages along the analytical procedure, due to the low volatility of the analytes, the diversity of potential contaminants, and to the low concentrations of certain substances of interest. Sample preparation, the use of derivatization agents, different operating modes of the mass spectrometer for the detection, and the diverse application fields of the GC-MS analysis of illicit drugs are discussed in this article together with the presentation of some examples of these applications.

Referências Bibliográficas

1. Dong-Liang L, Sheng-Meng W, Chih-Hung W, Bud-Gen C, Ray L. Chemical derivatization for the analysis of drugs by GC-MS – A conceptual review. Journal of Food and Drug Analysis 2008; 16(1):1-10.
2. Marais A, Laurens J. Rapid GC-MS confirmation of amphetamines in urine by extractive acylation. Forensic Science International 2009; 183:78-86. http://
3. Langel K, Gunnar T, Ariniemi K, Rajamäki, O, Lillsunde P. A validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatographymass spectrometry. Journal of Chromatography B 2011; 879:859-870. jchromb.2011.02.027
4. Sachs H, Kintz P. Testing for drugs in hair: Critical review of chromatographic procedures since 1992. Journal of Chromatography B 1998; 713:147-161.
5. Pragst F, Balikova M. State of the art in hair analysis for detection of drug and alcohol abuse. Clinica Chimica Acta 62006; 370:17-49. cca.2006.02.019
6. Drummer O. Introduction and review of collection techniques and applications of drug testing of oral fluid. Therapeutic Drug Monitoring 2008; 30:203-206.
7. Schramm W, Smith R, Craig P, Kidwell D. Drugs of abuse in saliva: A review. Journal of Analytical Toxicology 1992; 16:1-9.
8. Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. Journal of Chromatography B 1998; 713:137-146. S0378-4347(97)00479-9
9. Cordero R, Paterson S. Simultaneous quantification of opiates, amphetamines, cocaine and metabolites and diazepam and metabolite in a single hair sample using GC-MS. Journal of Chromatography B 2007; 850:423- 431..
10. Madej K. Analysis of meconium, nails and tears for determination of medicines and drugs of abuse. Trends in Analytical Chemistry 2010; 29(3):246-259.
11. Fríguls B, Joya X, García-Algar O, Pallás C, Vall O, Pichini S. A comprehensive review of assay methods to determine drugs in breast milk and the safety of breastfeeding when taking drugs. Analytical and Bioanalytical Chemistry 2010; 397:1157-1179. http://
12. González-Mariño I, Quintana J, Rodríguez I, Cela R. Determination of drugs of abuse in water by solid-phase extraction, derivatisation and gas chromatography-ion trap-tandem mass spectrometry. Journal of Chromatography A 2010; 1217:1748-1760.
13. Kishi T, Inoue T, Suzuke S, Yasuda T, Okikawa T, Niwaguchi T. Analysis of impurities in methamphetamine. Eisei Kagaku 1983; 29:39- 48.
14. Emde H. Über diastereomerie I. Konfiguration des ephedrines. Helvetica Chimica Acta 1929; 12:365-376.
15. Ko B, Suh S, Suh Y, In M, Kim S. The impurity characteristics of methamphetamine synthesized by Emde and Nagai method. Forensic Science International 2007;170:142-147. http://dx.doi. org/10.1016/j.forsciint.2007.03.029
16. Strömberg L, Lundberg L, Neumann H, Bobon B, Huizer H, Van Der Stelt N. Heroin impurity profiling. A harmonization study for retrospective comparisons. Forensic Science International 2000; 114:67-88. http://
17. Lociciro S, Hayoz P, Esseiva P, Dujourdy L, Besacier F, Margot P. Cocaine profiling for strategic intelligence purposes, a cross-border project between France and Switzerland. Part I. Optimisation and harmonisation of the profiling method. Forensic Science International 2007; 167:220-228. http://dx.doi. org/10.1016/j.forsciint.2006.06.052
18. Weyermann C, Marquis R, Delaporte C, Esseiva P, Lock E, Aalberg L et al. Drug intelligence based on MDMA tablets data I. Organic impurities profiling. Forensic Science International 2008; 177:11-16. http://
19. Kolbrich E, Lowe R, Huestis M. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma. Clinical Chemistry 2008; 54(2):379-387.
20. Scurlock R, Ohlson G, Worthen D. The detection of Δ9-tetrahydrocannabinol (THC) and 11-nor-9- carboxy-Δ9-tetrahydrocannabinol (THCA) in whole blood using two-dimensional gas chromatography and EI-mass spectrometry. Journal of Analytical Toxicology 2006; 30:262-266.
21. Lowe R, Karschner E, Schwilke E, Barnes A, Huestis M. Simultaneous quantification of Δ9-tetrahydrocannabinol, 11.-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-Δ9- tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. Journal of Chromatography A 2007; 1163:318-327.
22. Karschner E, Barnes A, Lowe R, Scheidweiler K, Huestis M. Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol (THC),11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma. Analytical and Bioanalytical Chemistry 2010; 397:603-611. http://
23. Moore C, Coulter C, Rana S, Vincent M, Soares J. Analytical procedure for the determination of the marijuana metabolite 11-nor-Δ9-tetrahydrocannabinol- 9.-carboxylic acid in oral fluid specimens. Journal of Analytical Toxicology 2006; 30:409-412.
24. Moore C, Rana S, Coulter C, Day D, Vincent M, Soares J. Detection of conjugated 11-nor-Δ9- tetrahydrocannabinol-9-carboxylic acid in oral fluid. Journal of Analytical Toxicology 2007; 31:187-194.
25. Moore C, Rana S, Coulter C, Feyerherm F, Prest H. Application of two-dimensional gas chromatography with electron capture chemical ionization mass spectrometry to the detection of 11-nor-Δ9- tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair. Journal of Analytical Toxicology 2006; 30:171-177.
26. Marin S, Coles R, Urry F, McMillin G. Confirmation of cannabinoids in meconium using two-dimensional gas chromatography with mass spectrometry detection. Journal of Chromatography B 2007; 858:59-64. http://
27. Harynuk J, Marriott P. GS-MS principles and instrumentation: comprehensive two-dimensional gas chromotography mass spectrometry. In: Caprioli R, editor. The Encyclopedia of Mass Spectrometry. Oxford: Elsevier; 2006. vol. 8: Hyphenated Methods, cap. 2, p. 83-92.
28. Mitrevski B, Veleska B, Engel E, Wynne P, Song S, Marriott P. Chemical signature of ecstasy volatiles by comprehensive two-dimensional gas chromatography. Forensic Science International 2011; 209:11-20. http://dx.doi. org/10.1016/j.forsciint.2010.11.008
29. Mitrevski B, Wynne P, Marriott P. Comprehensive two-dimensional gas chromatography applied to illicit drug analysis. Analytical and Bioanalytical Chemistry 2011; 401:2361-2371. http://dx.doi. org/10.1007/s00216-011-5234-6
30. Song S, Marriott P, Wynne P. Comprehensive two-dimensional gas chromatography with timeof- flight mass spectrometry (GC × GC-TOFMS) for drug screening and confirmation. Journal of Chromatography A 2004; 1058:223-232. http://dx.doi. org/10.1016/S0021-9673(04)01444-X
31. Guthery B, Bassindale T, Bassindale A, Pillinger C, Morgan G. Qualitative drug analysis of hair extracts by comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry. Journal of Chromatography A 2010; 1217:4402-4410.
32. Georgakopoulos C, Vonaparti A, Stamou M, Kiousi P, Lyris E, Angelis Y et al. Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids. Rapid Communications in Mass Spectrometry 2007; 21:2439-2446. http://dx.doi. org/10.1002/rcm.3103
33. Pavlic M, Libiseller K, Oberacher H. Combined use of ESI-QqTOF-MS and ESI-QqTOF-MS/ MSwith mass-spectral library search for qualitative analysis of drugs. Analytical and Bioanalytical Chemistry 2006; 386:69-82. http://dx.doi. org/10.1007/s00216-006-0634-8.